CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
FSH-IBSA +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00378001
NCT00378001Phase 3Completed
CompareCT.gov

A Prospective, Multicenter, Investigator Blinded, Randomized, Concurrent Control Study of Efficacy and Tolerability of Two FSH Preparations (Fostimon® Versus Gonal-F®) in Women Undergoing IVF

IBSA Institut Biochimique SA·interventional·Posted Sep 19, 2006·Updated Feb 16, 2015

In Brief

A Phase 3 clinical trial evaluating FSH-IBSA and GONAL-F for Infertility. Completed, across 4 sites.

Detailed Summary

The purpose of the study is to evaluate the clinical efficacy and general tolerability of two different subcutaneous FSH preparations (Fostimon®, IBSA vs Gonal-F®, Serono Inc.) when administered to patients undergoing controlled ovarian stimulation for IVF.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfertility
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 19, 2006
Enrollment StartMar 1, 2005
Primary CompletionMay 1, 2006
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 19.8 years ago

Interventions

FSH-IBSAdrug

GONAL-Fdrug